General Information of the Compound
| Compound ID |
CP0467899
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-amino-3-(N-methylpiperidin-4-yl)-1H-indole
Show/Hide
|
||||||||||||||||||
| Synonyms |
182564-38-1
3-(1-Methyl-4-piperidinyl)-5-amino-1H-indole
3-(1-methyl-4-piperidyl)indole-5-ylamine
3-(1-methylpiperidin-4-yl)-1h-indol-5-amine
5-amino-3-(1-methylpiperidin-4-yl)-1H-indole
5-amino-3-(N-methylpiperidin-4-yl)-1H-indole
AKOS024098950
BDBM50271135
CHEMBL521235
CKBJZDHVHHKARV-UHFFFAOYSA-N
CTK6I2276
SCHEMBL427406
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C14H19N3
|
||||||||||||||||||
| Molecular Weight |
229.327
|
||||||||||||||||||
| Canonical SMILES |
CN1CCC(CC1)c1c[nH]c2ccc(N)cc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C14H19N3/c1-17-6-4-10(5-7-17)13-9-16-14-3-2-11(15)8-12(13)14/h2-3,8-10,16H,4-7,15H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
CKBJZDHVHHKARV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01202, 5-hydroxytryptamine receptor 1B
Protein ID: PT00827, 5-hydroxytryptamine receptor 1D
Clinical Information about the Compound